Evaluating Serum Periostin and YKL-40 As Biomarkers for Airway Remodeling and Hyperresponsiveness in Pediatric Asthma

Overview

Journal World Allergy Organ J

Specialty Allergy & Immunology

Date 2024 Nov 13

PMID 39534447

Authors

Su Ji Kim

Youn Joo Choi

Man Yong Han

Il Tae Hwang

Hey-Sung Baek

Affiliations

Soon will be listed here.

Abstract

Background: Periostin and human chitinase-3-like protein 1 (YKL-40) have been suggested to be involved in the development of airway fibrosis and remodeling. This study aimed to investigate the relationship between serum periostin levels and airway hyperresponsiveness (AHR) and between serum YKL-40 levels and AHR in children with asthma, comparing periostin as a marker for Th2 inflammation and atopy with YKL-40.

Methods: The study involved children aged 6-15 years, comprising 75 with asthma and 29 healthy controls. We measured serum periostin and YKL-40 levels and performed exercise bronchial provocation tests, methacholine challenge tests, spirometry, and FeNO measurements.

Results: Compared to the healthy controls, asthmatic children exhibited significantly elevated levels of periostin (86.7 [71.0-104.0] vs 68.3 [56.0-82.0] ng/mL; P = 0.006) and YKL-40 (29.0 [15.0-39.5] vs 27.7 [14.0-34.1] ng/mL; P = 0.034). The subgroup analysis revealed that periostin levels were significantly higher in the atopic asthma group than in the healthy controls (P = 0.003), but not in the non-atopic asthma group. YKL-40 levels were elevated in both the atopic and non-atopic asthma groups compared to healthy controls (P = 0.012 and P = 0.001, respectively). Serum periostin levels were significantly correlated with the postexerceise maximum percentage decrease in forced expiratory volume (FEV), as well as with fractional exhaled nitric oxide (FeNO) and blood eosinophil counts, but showed no significant correlation with overall lung function. Conversely, serum YKL-40 levels were significantly linked to the Z score of FEV and AHR to methacholine but not with AHR to exercise or FeNO or blood eosinophil count.

Conclusions: Periostin is linked to atopic asthma and correlates with exercise-induced bronchoconstriction, FeNO, and eosinophil counts, highlighting its role in Th2 inflammation. YKL-40 is a general asthma marker, indicating airway remodeling. These findings suggest that targeting these markers can improve personalized treatment strategies for pediatric asthma.

References

Konradsen J, James A, Nordlund B, Reinius L, Soderhall C, Melen E . The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma. J Allergy Clin Immunol. 2013; 132(2):328-35.e5. DOI: 10.1016/j.jaci.2013.03.003. View

. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171(8):912-30. DOI: 10.1164/rccm.200406-710ST. View

Ober C, Tan Z, Sun Y, Possick J, Pan L, Nicolae R . Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med. 2008; 358(16):1682-91. PMC: 2629486. DOI: 10.1056/NEJMoa0708801. View

Wenzel S . Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes. Am J Respir Crit Care Med. 2020; 203(7):809-821. PMC: 8017568. DOI: 10.1164/rccm.202009-3631CI. View

Tong X, Wang D, Liu S, Ma Y, Li Z, Tian P . The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review. Int J Chron Obstruct Pulmon Dis. 2018; 13:409-418. PMC: 5796800. DOI: 10.2147/COPD.S152655. View

Naik P, Bozyk P, Bentley J, Popova A, Birch C, Wilke C . Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012; 303(12):L1046-56. PMC: 3532583. DOI: 10.1152/ajplung.00139.2012. View

Letuve S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret M . YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol. 2008; 181(7):5167-73. DOI: 10.4049/jimmunol.181.7.5167. View

Varricchi G, Ferri S, Pepys J, Poto R, Spadaro G, Nappi E . Biologics and airway remodeling in severe asthma. Allergy. 2022; 77(12):3538-3552. PMC: 10087445. DOI: 10.1111/all.15473. View

Parsons J, Hallstrand T, Mastronarde J, Kaminsky D, Rundell K, Hull J . An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 2013; 187(9):1016-27. DOI: 10.1164/rccm.201303-0437ST. View

10.

Crapo R, Casaburi R, Coates A, Enright P, Hankinson J, Irvin C . Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161(1):309-29. DOI: 10.1164/ajrccm.161.1.ats11-99. View

11.

Cho J, Kim K, Yoon J, Choi S, Sheen Y, Han M . Serum levels of periostin and exercise-induced bronchoconstriction in asthmatic children. World Allergy Organ J. 2019; 12(1):100004. PMC: 6439409. DOI: 10.1016/j.waojou.2018.11.004. View

12.

ODwyer D, Moore B . The role of periostin in lung fibrosis and airway remodeling. Cell Mol Life Sci. 2017; 74(23):4305-4314. PMC: 5659879. DOI: 10.1007/s00018-017-2649-z. View

13.

Chupp G, Lee C, Jarjour N, Shim Y, Holm C, He S . A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med. 2007; 357(20):2016-27. DOI: 10.1056/NEJMoa073600. View

14.

Anderson S . Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010; 138(2 Suppl):25S-30S. DOI: 10.1378/chest.10-0116. View

15.

Brannan J, Gulliksson M, Anderson S, Chew N, Kumlin M . Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J. 2003; 22(3):491-6. DOI: 10.1183/09031936.03.00113403. View

16.

Song J, You J, Jeong S, Yang S, Hwang I, Im Y . Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015; 70(6):674-81. DOI: 10.1111/all.12599. View

17.

Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, Fujimoto K . Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J. 2010; 37(5):1119-27. DOI: 10.1183/09031936.00059810. View

18.

Woodruff P, Modrek B, Choy D, Jia G, Abbas A, Ellwanger A . T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009; 180(5):388-95. PMC: 2742757. DOI: 10.1164/rccm.200903-0392OC. View

19.

McGregor M, Krings J, Nair P, Castro M . Role of Biologics in Asthma. Am J Respir Crit Care Med. 2018; 199(4):433-445. PMC: 6835092. DOI: 10.1164/rccm.201810-1944CI. View

20.

Tang H, Sun Y, Shi Z, Huang H, Fang Z, Chen J . YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration. J Immunol. 2012; 190(1):438-46. DOI: 10.4049/jimmunol.1201827. View